"immune checkpoint inhibitor antibody" trang 3 - tải miễn phí từ tailieunhanh
Comprehensive analysis of the role of ICOS ( CD278 ) in pan-cancer prognosis and immunotherapy

Comprehensive analysis of the role of ICOS ( CD278 ) in pan-cancer prognosis and immunotherapy
15    5    1
Combination of alpha-fetoprotein and neutrophil-to-lymphocyte ratio to predict treatment response and survival outcomes of patients with unresectable hepatocellular carcinoma treated with immune checkpoint

Combination of alpha-fetoprotein and neutrophil-to-lymphocyte ratio to predict treatment response and survival outcomes of patients with unresectable hepatocellular carcinoma treated with immune checkpoint
11    7    1
Baseline C-reactive protein predicts efcacy of the first-line immune checkpoint inhibitors plus chemotherapy in advanced lung squamous cell carcinoma: A retrospective, multicenter study

Baseline C-reactive protein predicts efcacy of the first-line immune checkpoint inhibitors plus chemotherapy in advanced lung squamous cell carcinoma: A retrospective, multicenter study
10    1    1
Radiomics-based prediction of response to immune checkpoint inhibitor treatment for solid cancers using computed tomography: A real-world study of two centers

Radiomics-based prediction of response to immune checkpoint inhibitor treatment for solid cancers using computed tomography: A real-world study of two centers
11    5    1
Identification of CEACAM5 as a stemness-related inhibitory immune checkpoint in pancreatic cancer

Identification of CEACAM5 as a stemness-related inhibitory immune checkpoint in pancreatic cancer
14    4    1
Association of Helicobacter pylori infection with survival outcomes in advanced gastric cancer patients treated with immune checkpoint inhibitors

Association of Helicobacter pylori infection with survival outcomes in advanced gastric cancer patients treated with immune checkpoint inhibitors
8    1    1
Significance of CD103+ tissue-resident memory T cells for predicting the effectiveness of immune checkpoint inhibitors in esophageal cancer

Significance of CD103+ tissue-resident memory T cells for predicting the effectiveness of immune checkpoint inhibitors in esophageal cancer
12    1    1
Inhibition of hyperprogressive cancer disease induced by immune-checkpoint blockade upon co-treatment with meta-tyrosine and p38 pathway inhibitor

Inhibition of hyperprogressive cancer disease induced by immune-checkpoint blockade upon co-treatment with meta-tyrosine and p38 pathway inhibitor
17    11    1
Rare, late onset of immune checkpoint inhibitor-induced type 1 diabetes mellitus in a patient with small-cell lung cancer treated with serplulimab: A case report and review of the literature

Rare, late onset of immune checkpoint inhibitor-induced type 1 diabetes mellitus in a patient with small-cell lung cancer treated with serplulimab: A case report and review of the literature
7    6    1
Mononeuritis multiplex as a rare and severe neurological complication of immune checkpoint inhibitors: A case report

Mononeuritis multiplex as a rare and severe neurological complication of immune checkpoint inhibitors: A case report
5    13    1
Waldenström macroglobulinemia with secondary pure red cell aplasia in a patient with metastatic castrate resistant prostate cancer receiving an immune checkpoint inhibitor: A case report

Waldenström macroglobulinemia with secondary pure red cell aplasia in a patient with metastatic castrate resistant prostate cancer receiving an immune checkpoint inhibitor: A case report
5    15    1
Pan-immune-inflammation and its dynamics: Predictors of survival and immune-related adverse events in patients with advanced NSCLC receiving immunotherapy

Pan-immune-inflammation and its dynamics: Predictors of survival and immune-related adverse events in patients with advanced NSCLC receiving immunotherapy
11    6    1
Immune checkpoint inhibitors-related myocarditis in patients with cancer: An analysis of international spontaneous reporting systems

Immune checkpoint inhibitors-related myocarditis in patients with cancer: An analysis of international spontaneous reporting systems
9    38    1
Immune checkpoint inhibitors plus neoadjuvant chemotherapy in early triplenegative breast cancer: A systematic review and meta-analysis

Immune checkpoint inhibitors plus neoadjuvant chemotherapy in early triplenegative breast cancer: A systematic review and meta-analysis
10    53    1
Correlation between immune-related adverse events and prognosis in patients with gastric cancer treated with nivolumab

Correlation between immune-related adverse events and prognosis in patients with gastric cancer treated with nivolumab
10    72    0
Prospective correlation between the patient microbiome with response to and development of immune-mediated adverse effects to immunotherapy in lung cancer

Prospective correlation between the patient microbiome with response to and development of immune-mediated adverse effects to immunotherapy in lung cancer
14    51    1
Correlation between immune-related adverse events and therapeutic efects of nivolumab in patients with malignant pleural mesothelioma

Correlation between immune-related adverse events and therapeutic efects of nivolumab in patients with malignant pleural mesothelioma
6    29    1
Multi-omics analysis of an immune-based prognostic predictor in non-small cell lung cancer

Multi-omics analysis of an immune-based prognostic predictor in non-small cell lung cancer
19    57    3
Digital gene expression analysis of NSCLC-patients reveals strong immune pressure, resulting in an immune escape under immunotherapy

Digital gene expression analysis of NSCLC-patients reveals strong immune pressure, resulting in an immune escape under immunotherapy
13    55    3
Abundant expression of ferroptosis-related SAT1 is related to unfavorable outcome and immune cell infiltration in low-grade glioma

Abundant expression of ferroptosis-related SAT1 is related to unfavorable outcome and immune cell infiltration in low-grade glioma
15    21    1